(Updated - May 6, 2024 6:50 AM EDT)

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.31), EUR0.18 worse than the analyst estimate of (EUR1.13). Revenue for the quarter came in at EUR187.6 million versus the consensus estimate of EUR305 million.

BioNTech still expects group revenues for the full 2024 financial year to be in the range of €2.5 billion to €3.1 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

Earnings Guidance